Co-Authors
This is a "connection" page, showing publications co-authored by W Wiersinga and Marcus Schultz.
Connection Strength
0.236
-
Clinical Characteristics and Outcomes of Patients With Cellulitis Requiring Intensive Care. JAMA Dermatol. 2017 06 01; 153(6):578-582.
Score: 0.180
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.057